Search Results - "Epstein–Barr virus"

Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications.

Mark JKK; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia., Teh AH; Centre for Chemical Biology, Universiti Sains Malaysia, 11900, Bayan Lepas, Penang, Malaysia., Yap BK; School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia. beowkeat@usm.my.

Journal Article; Review , 2025

Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals.

Trier NH; Department of Neurology, Rigshospitalet Glostrup, Valdemar Hansens vej 13, Glostrup, Denmark. Electronic address: nicole.hartwig.trier@regionh.dk., Zivlaei N; Department of Neurology, Rigshospitalet Glostrup, Valdemar Hansens vej 13, Glostrup, Denmark. Electronic address: nadia.zivlaei@regionh.dk., Ostrowski SR; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen OE, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, BLegdamsvej 3B, 2200 Copenhagen N, Denmark. Electronic address: sisse.rye.ostrowski@regionh.dk., Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen OE, Denmark. Electronic address: erik.soerensen@regionh.dk., Larsen M; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen OE, Denmark. Electronic address: margit.larsen@regionh.dk., Slibinskas R; Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania. Electronic address: rimantas.slibinskas@bti.vu.lt., Ciplys E; Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania. Electronic address: evaldas.ciplys@bti.vu.lt., Frederiksen JL; Department of Neurology, Rigshospitalet Glostrup, Valdemar Hansens vej 13, Glostrup, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, BLegdamsvej 3B, 2200 Copenhagen N, Denmark. Electronic address: jette.lautrup.battistini@region.dk., Houen G; Department of Neurology, Rigshospitalet Glostrup, Valdemar Hansens vej 13, Glostrup, Denmark; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55 5230 Odense M, Denmark. Electronic address: gunnar.houen@regionh.dk.

Journal Article , 2025

Epstein-Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging.

Orr N; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305-5316., Steinman L; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305-5316.; Department of Pediatrics, Stanford University, Stanford, CA 94305-5316.

Journal Article , 2025

Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk.

Li J; The First College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, No. 71, Baoshan North Road, Yunyan District, Guiyang, 550001, Guizhou, China.; Guizhou University of Traditional Chinese Medicine, No. 4, Dongqing Road, Huaxi District, Guiyang, 550025, Guizhou, China., Tan R; Department of Pharmaceutics, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China., Yang B; The First College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, No. 71, Baoshan North Road, Yunyan District, Guiyang, 550001, Guizhou, China.; Student Management Office, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China., Du C; The First College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, No. 71, Baoshan North Road, Yunyan District, Guiyang, 550001, Guizhou, China.; Guizhou University of Traditional Chinese Medicine, No. 4, Dongqing Road, Huaxi District, Guiyang, 550025, Guizhou, China., Tian J; The First College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, No. 71, Baoshan North Road, Yunyan District, Guiyang, 550001, Guizhou, China. tianjie597@gzy.edu.cn.; Department of Oncology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China. tianjie597@gzy.edu.cn.; Guizhou University of Traditional Chinese Medicine, No. 4, Dongqing Road, Huaxi District, Guiyang, 550025, Guizhou, China. tianjie597@gzy.edu.cn., Yang Z; Guizhou University of Traditional Chinese Medicine, No. 4, Dongqing Road, Huaxi District, Guiyang, 550025, Guizhou, China. yangzhu20150426@163.com., Tang D; Department of Oncology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China. hemingankang@sina.com.; Guizhou University of Traditional Chinese Medicine, No. 4, Dongqing Road, Huaxi District, Guiyang, 550025, Guizhou, China. hemingankang@sina.com.

Journal Article , 2025

Metabolic Reprogramming in Epstein-Barr Virus Associated Diseases.

Yee TM; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Wang LW; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.

Journal Article; Review , 2025

Intelligent Hierarchical Targeting Near-Infrared Persistent Luminescence Nanosystem for Improved Nuclear Delivery and Simultaneous Visualization/Therapy of EBV-Associated Cancer.

Zhu Y; Ministry of Education Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Optoelectronic Materials and Technologies, School of Chemistry, Sun Yat-sen University, Guangzhou 510275, China., Wen Y; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China., Xie Y; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China., Chen G; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China., Hu S; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China., Wu Y; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Jiang L; Hubei Key Laboratory of Genetic Regulation & Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, China., Viana B; PSL Research University, Chimie ParisTech, Chemistry Research Institute of Paris (IRCP), French National Center for Scientific Research (CNRS), 75005 Paris, France., Richard C; CNRS, INSERM, UTCBS, Université Paris Cité, 75006 Paris, France., Wong KL; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Jiao J; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China., Wang J; Ministry of Education Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Optoelectronic Materials and Technologies, School of Chemistry, Sun Yat-sen University, Guangzhou 510275, China., Zou R; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou 510630, China.

Journal Article , 2025

A Bidirectional Mendelian Randomization Study on the Causal Relationship Between Epstein-Barr Virus Antibodies and Prostate Cancer Risk.

Ding XB; Department of Ultrasound, Sir Run Run Shaw Hospital, Hangzhou, China., Ren SY; Department of Radiation Oncology, Sir Run Run Shaw Hospital, Hangzhou, China., Wen HZ; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., Zhang ZB; Department of Orthopedic Surgery, Longquan People's Hospital, Lishui, China., Ye JA; Department of Stomatology, Jining Medical University, Jining, China., Pan WK; Department of Nuclear Medicine, Sir Run Run Shaw Hospital, Hangzhou, China., Ye JQ; Department of Radiotherapy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.

Journal Article , 2025

TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice.

Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Chen Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Wang S; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zhong L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Xiang Z; Department of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, People's Republic of China., Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; College of Pharmacy, Chongqing Medical University, Chongqing, People's Republic of China., Zhang S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China., Zhou X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China., Zhang W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Zhou Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Zhang Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Liang J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Luo Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Wang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Chen L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Ye X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Feng Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Zeng MS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Liu Y; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zeng YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Shao Y; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.; Changping Laboratory, Beijing, People's Republic of China., Xu M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.

Journal Article , 2024

EBV-specific T-cell immunity: relevance for multiple sclerosis.

Behrens M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany., Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Barcelona, Spain., Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.

Journal Article; Review , 2024

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.

Vasilenko N; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany., Tieck MP; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Michel T; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Schembecker S; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany., Schwarz P; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Guenther A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Ruschil C; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Poli S; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Ziemann U; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Giede-Jeppe A; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany., Gabernet G; Department of pathology, Yale School of Medicine, New Haven, CT, United States., Dulovic A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kowarik MC; Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany.; Department of Neurology & Stroke, Eberhard-Karls, University of Tübingen, Tübingen, Germany.

Journal Article , 2024

Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.

Ma L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; School of Public Health, Sun Yat-sen University, Guangzhou, China., Wang TM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China., He YQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Liao Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Yan X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Yang DW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; School of Public Health, Sun Yat-sen University, Guangzhou, China., Wang RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Li FJ; Guangdong Key Laboratory of Human Evolution and Archaeometry, Department of Anthropology, School of Sociology and Anthropology, Sun Yat-sen University, Guangzhou, China., Jia WH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.; School of Public Health, Sun Yat-sen University, Guangzhou, China., Feng L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.

Journal Article , 2024

The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.

Warner BE; Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania., Patel J; Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania., Wang R; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania., Adams-Haduch J; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Koh WP; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wong KW; Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Chiang AKS; Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Yuan JM; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania., Shair KHY; Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.

Journal Article , 2024

Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection.

Ding B; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Zhang Y; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Wu Y; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Li Y; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Journal Article , 2024

Greater humoral EBV response may be associated with choroid plexus inflammation in progressive MS.

Jakimovski D; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St, Buffalo, NY, 14203, USA. djakimovski@bnac.net.; Wynn Hospital, Mohawk Valley Health System, Utica, NY, 13502, USA. djakimovski@bnac.net., Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St, Buffalo, NY, 14203, USA.; Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA., Ramanathan M; Department of Pharmaceutical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA., Weinstock-Guttman B; Department of Neurology, Jacobs Comprehensive MS Treatment and Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA., Tavazzi E; Multiple Sclerosis Centre, IRCCS Mondino Foundation, Pavia, Italy., Dwyer MG; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St, Buffalo, NY, 14203, USA., Bergsland N; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St, Buffalo, NY, 14203, USA.

Journal Article , 2024

Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder.

Shi Z; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Kong L; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Wang R; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Wang X; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Wang Z; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Luo W; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Chen H; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Du Q; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Sun D; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China., Zhou H; Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China. zhouhy@scu.edu.cn.

Journal Article , 2024

Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFNβ expression.

Landman SL; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Oncode Institute, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Ressing ME; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Gram AM; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Tjokrodirijo RTN; Center for Proteomics & Metabolomics, LUMC, Leiden, the Netherlands., van Veelen PA; Center for Proteomics & Metabolomics, LUMC, Leiden, the Netherlands., Neefjes J; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Oncode Institute, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., van der Veen AG; Department of Immunology, LUMC, Leiden, the Netherlands., Berlin I; Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Oncode Institute, Leiden University Medical Center (LUMC), Leiden, the Netherlands. Electronic address: i.berlin@lumc.nl.

Journal Article , 2024

The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.

Sun K; The Tumor Virology Program, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bose D; The Tumor Virology Program, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Singh RK; The Tumor Virology Program, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Pei Y; School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, Guangdong, China., Robertson ES; The Tumor Virology Program, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Journal Article , 2024

Polymerase theta is a synthetic lethal target for killing Epstein-Barr virus lymphomas.

Willman GH; Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA., Xu H; Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA., Zeigler TM; Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA., McIntosh MT; Child Health Research Institute, Department of Pediatrics, University of Florida, Gainesville, Florida, USA.; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA., Bhaduri-McIntosh S; Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, Florida, USA.; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.

Journal Article , 2024

The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis.

Liu H; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Lei L; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Song S; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Geng X; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Lin K; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Li N; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Chen W; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Peng J; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Ren J; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. ren.js@cicams.ac.cn.

Journal Article; Meta-Analysis , 2024

Association of Epstein-Barr virus (EBV) with nasopharyngeal carcinoma: Experience from a North Indian tertiary care hospital.

Biswal D; Department of Microbiology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, Haryana, India. Electronic address: debasishbiswal138@gmail.com., Brijwal M; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: megha.brijwal@yahoo.com., Choudhary A; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: aashishpath@yahoo.co.in., Kakkar A; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: aanchalkakkar@gmail.com., Pramanik R; Department of Medical Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India. Electronic address: drrajapramanik@gmail.com., Thakar A; Department of Otolaryngology & Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India. Electronic address: drathakar@gmail.com., Dar L; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: lalitdaraiims@gmail.com.

Journal Article , 2024